— Know what they know.
Not Investment Advice

AKYA NASDAQ

Akoya Biosciences, Inc.
1W: +0.0% 1M: +4.9% 3M: +3.2% 1Y: -44.2% 3Y: -90.5%
$1.29
Last traded 2025-07-16 — delisted
NASDAQ · Healthcare · Medical - Instruments & Supplies · $64.4M mcap · 13M float · 4.62% daily turnover · Short 13% of daily vol

Edge Score

Quantitative competitive moat analysis scoring five pillars of durable advantage — cost leadership, brand intangibles, switching costs, network effects, and efficient scale — using industry percentile rankings on a 0–100 scale.

WEAK EDGE
48.7 / 100
NoneWeakNarrowWide
Primary source: Intangible Assets  ·  ROIC: -60.6%
Cost Advantage
34
Intangibles
73
Switching Cost
32
Network Effect
69
Scale
35
The Edge Score quantifies a company's competitive moat using five pillars: Cost Advantage (20%, operating margin and SG&A efficiency vs industry peers), Intangible Assets (25%, gross margin premium, R&D intensity, brand pricing power), Switching Costs (25%, revenue stability, earnings consistency, customer retention proxied by operating leverage), Network Effects (15%, revenue growth with expanding margins, market share dominance), and Efficient Scale (15%, market concentration, ROIC sustainability). Each pillar is scored 0–100 using industry percentile rankings, then weighted into a composite. Wide ≥ 70, Narrow ≥ 55, Weak ≥ 40, None < 40. AKYA shows a Weak competitive edge (48.7/100) — limited structural advantages that may face competitive pressure. The primary source of advantage is Intangible Assets. Negative ROIC of -60.6% indicates the company is currently destroying value, though this may reflect a growth investment phase.

Analyst Insights

Wall Street analyst consensus based on price targets and buy/sell/hold recommendations from institutional research coverage over the trailing 12 months.

Analyst Price Targets
Analyst Recommendations
Strong Buy: 0Buy: 2Hold: 7Sell: 0Strong Sell: 0
Rating Summary
ConsensusHold
Avg Target$—
Analysts0
Price Target Change History
DateFirmAnalystOldNewChangeUpside @ CallStock@Call
2025-03-05 Piper Sandler — $4 $2 -2 +50.0% $1.60
2024-11-15 Piper Sandler Dave Westenberg $17 $4 -13 +72.4% $2.32
2024-08-06 Morgan Stanley Tejas Savant $4 $3 -1 +49.3% $2.01
2024-06-21 Craig-Hallum Bill Bonello Initiated $8 — +236.3% $2.23
2024-06-03 Morgan Stanley Tejas Savant Initiated $4 — +86.0% $2.15
2024-05-14 BTIG Mark Massaro Initiated $6 — +45.6% $4.12
2024-05-14 Canaccord Genuity Kyle Mikson Initiated $6 — +45.6% $4.12
2022-08-17 Piper Sandler David Westenberg Initiated $17 — +27.4% $13.34

InsiderStreet Scorecard

Proprietary multi-factor scorecard rating companies across seven fundamental dimensions — profitability, balance sheet strength, earnings quality, growth, value, momentum, and safety — each scored 0–100.

★ ★ ★ ★ ★ 22 Grade D
Profitability
18
Balance Sheet
29
Earnings Quality
42
Growth
56
Value
15
Momentum
56
Safety
0
Cash Flow
30
The InsiderStreet Scorecard rates companies across eight dimensions: Profitability (margins, ROA, ROE), Balance Sheet (leverage, liquidity, coverage), Earnings Quality (accruals, cash conversion), Growth (revenue and earnings trajectory), Value (P/E, P/B, earnings yield, Graham criteria), Momentum (revenue and earnings acceleration), Safety (Altman Z-Score risk adjustment), and Cash Flow (operating cash flow quality, FCF conversion, cash coverage). The overall score blends 35% quality, 35% value, and 30% momentum, with a penalty for distress-zone Altman scores. AKYA scores highest in Momentum (56/100) and lowest in Safety (0/100). A grade of D flags significant fundamental concerns across multiple dimensions.

Risk & Quality Signals

Academic financial models used by institutional investors to assess bankruptcy risk, earnings manipulation, financial strength, and credit quality.

Altman Z-Score
-4.22
Distress Zone
Piotroski F-Score
3/9
✗ ✗ ✓ ✓ ✗ ✗ ✗ ✓ ✗
Beneish M-Score
-3.44
Unlikely Manipulator
Ohlson O-Score
-1.92
Bankruptcy prob: 12.8%
Moderate
Credit Rating
CCC
Score: 12.7/100
Trend: Deteriorating
Earnings Quality
—
OCF/NI: 0.64x
Accruals: -12.7%
The Altman Z-Score (1968) combines five ratios — working capital, retained earnings, EBIT, market value of equity, and sales, all relative to total assets or liabilities — into a single bankruptcy predictor. AKYA scores -4.22, placing it in the Distress Zone (safe > 2.99, distress < 1.81). Historically, companies in this range face elevated bankruptcy risk. The Piotroski F-Score (2000) is a 9-point binary checklist — four profitability tests (positive ROA, positive cash flow, improving ROA, cash flow exceeding net income), three leverage tests (declining debt ratio, improving current ratio, no share dilution), and two efficiency tests (improving gross margin, improving asset turnover). Each pass scores 1 point. AKYA scores 3/9, suggesting weak financial fundamentals — the company fails the majority of these accounting tests. The Beneish M-Score (1999) is an 8-variable model that detects earnings manipulation by comparing year-over-year changes in receivables, gross margins, asset quality, sales growth, depreciation, SG&A, leverage, and accruals. Scores above −1.78 statistically resemble past manipulators. AKYA's score of -3.44 falls below this threshold, suggesting earnings are unlikely to be manipulated. The Ohlson O-Score (1980) is a 9-variable logistic regression that estimates bankruptcy probability using firm size, leverage, working capital, current ratio, profitability (ROA), cash flow coverage, negative equity flag, consecutive losses flag, and earnings trajectory. The raw score is converted to a probability via logistic transformation. AKYA's implied 12.8% bankruptcy probability is elevated and warrants attention to the balance sheet. Our Credit Rating model scores companies on five weighted components — solvency (30%), earning power (25%), leverage (20%), liquidity (15%), and cash flow quality (10%) — then blends the absolute score with sector and industry peer rankings. For companies with large buyback programs, equity is adjusted by adding back cumulative 5-year repurchases (capped at 80% of FCF generated) to avoid penalizing shareholder-friendly capital allocation. AKYA receives an estimated rating of CCC (score: 12.7/100), with a deteriorating trend.

Valuation

Key valuation multiples comparing the stock's market price to its earnings, revenue, book value, and cash flows. Lower multiples may indicate relative undervaluation versus peers.

P/E
-1.15x
PEG
-0.03x
P/S
0.79x
P/B
8.39x
P/FCF
-2.13x
P/OCF
—
EV/EBITDA
-4.22x
EV/Revenue
1.57x
EV/EBIT
-3.38x
EV/FCF
-3.87x
Earnings Yield
-68.85%
FCF Yield
-46.85%
Shareholder Yield
0.00%
Graham Number
—
Equity-based multiples (P/E, P/B, P/FCF) compare the stock price to per-share fundamentals and are affected by capital structure. Enterprise value multiples (EV/EBITDA, EV/Revenue, EV/FCF) strip out debt and cash, making them more useful for cross-company comparisons regardless of how companies are financed. The Graham Number — √(22.5 × EPS × Book Value) — is Benjamin Graham's formula for the maximum price a defensive investor should pay. AKYA currently has negative earnings — the P/E ratio is not meaningful.

DuPont Decomposition (5-Factor)

The 5-factor DuPont framework breaks Return on Equity into its component drivers — tax efficiency, interest burden, operating profitability, asset utilization, and financial leverage — to reveal what truly drives shareholder returns.

Tax Burden
1.003
NI / EBT
×
Interest Burden
1.278
EBT / EBIT
×
EBIT Margin
-0.464
EBIT / Rev
×
Asset Turnover
0.598
Rev / Assets
×
Equity Multiplier
9.965
Assets / Equity
=
ROE
-354.3%
The 5-factor DuPont identity decomposes ROE as: Tax Burden × Interest Burden × EBIT Margin × Asset Turnover × Equity Multiplier = ROE. This reveals whether returns are driven by operating performance, financial leverage, or tax efficiency — three very different sources of profitability. AKYA's ROE of -354.3% is driven by financial leverage (equity multiplier: 9.96x). Note: high leverage means ROE is amplified by debt rather than operational performance. A tax burden ratio of 1.00 indicates minimal tax leakage — the company retains over 90% of pre-tax earnings.

Graham-Dodd Adjusted Valuation

Our adaptation of Graham's growth formula (Fair P/E = 8.5 + 2g) from The Intelligent Investor. The classic version relies on analyst growth projections, which can be unreliable. This adjusted model substitutes the company's realized 3-year EPS CAGR — a backward-looking, verifiable measure of actual earnings power — grounding the valuation in demonstrated performance rather than forecasts.

Two adjustments we make, and why. Growth is capped at 15%. Graham defined g as expected growth over the next seven to ten years, not last year's rate. Across US companies since 1994 the median realized 7-year EPS growth is 5–8% regardless of how fast a company grew beforehand, and of 4,457 company-quarters that grew faster than 200%, none sustained it. Uncapped, the formula assigned fair multiples in the hundreds to companies that had never held that rate — and scored worse than simply reading the P/E. Capped, it carries real information. The verdict has three states, not two. Tested over 377,249 stock-months, this ratio only separates outcomes at its extremes: below 0.25 beat the universe by 1.3 points a year, above 3.0 lagged by 2.7, and everything in between sat inside a one-point band. Rather than call two-thirds of the market "undervalued" on a threshold of 1.0, we say Neutral where the model cannot tell — which is most of the time.

Adj. Growth Rate
0.00%
Fair P/E
8.50x
Intrinsic Value
—
Price/Value
—
Margin of Safety
—
Premium
—

Profitability Trends

Historical profitability ratios tracking how efficiently the company converts revenue into returns for shareholders over time.

Leverage & Solvency Trends

Debt and liquidity metrics showing the company's financial leverage and ability to meet short-term and long-term obligations.

Efficiency & Working Capital Trends

Operating efficiency metrics measuring how quickly the company converts inventory to sales, collects receivables, and manages its cash conversion cycle.

Growth Trends (YoY %)

Year-over-year growth rates for key financial metrics, showing the trajectory of revenue, earnings, and cash flow generation.

Earnings Stability

R-squared of linear regression measuring how predictably revenue, earnings, and margins follow a trend over the trailing 5 years. 1.0 = perfectly predictable; lower values indicate erratic or cyclical behavior.

Monte Carlo Price Simulation

Geometric Brownian Motion with 1,000 antithetic paths over 1 year, seeded from 1067 days of historical volatility. Percentile bands show the range of statistically plausible outcomes — this is a statistical model, not a forecast.

Current Price
$1.29
Median 1Y
$0.47
5th Pctile
$0.13
95th Pctile
$1.68
Ann. Volatility
78.4%
25th–75th percentile 5th–95th percentile Median path Historical
All Ratios & Metrics

Complete fundamental data with up to 20 periods of history, sparkline trends, and current values across 13 categories and 130+ financial metrics.

Profitability
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Current
ROE -3.8% -12.5% -28.7% -48.1% -52.9% -65.4% -78.5% -98.3% -93.8% -1.0% -1.1% -1.8% -1.3% -1.5% -1.8% -3.5% -3.54%
ROA -2.7% -8.8% -18.3% -27.4% -32.4% -37.3% -38.5% -42.8% -40.9% -40.4% -35.5% -44.0% -36.3% -37.7% -36.3% -35.6% -35.55%
ROIC -11.1% -27.0% -65.0% -69.1% -80.5% -88.1% -98.4% -94.1% -1.0% -88.0% -79.7% -85.8% -67.9% -62.8% -65.1% -60.6% -60.57%
ROCE -2.6% -8.8% -20.0% -31.1% -39.9% -45.5% -47.5% -55.4% -45.6% -44.5% -37.6% -48.2% -45.5% -46.8% -46.9% -8.1% -8.12%
Gross Margin 62.2% 62.7% 63.3% 59.8% 57.8% 57.9% 56.8% 57.4% 51.5% 60.6% 55.7% 45.7% 57.8% 62.3% 67.4% 59.3% 59.32%
Operating Margin -48.8% -79.7% -1.0% -90.9% -97.6% -86.4% -80.6% -80.4% -81.8% -45.8% -33.3% -1.2% -47.9% -44.4% -26.8% -80.6% -80.61%
Net Margin -42.6% -86.2% -1.1% -97.1% -97.8% -94.8% -89.0% -87.8% -88.4% -51.2% -40.8% -1.3% -56.8% -56.0% -38.4% -94.1% -94.07%
EBITDA Margin -28.2% -71.4% -96.4% -82.9% -83.0% -78.5% -71.4% -68.2% -70.2% -32.1% -24.3% -1.0% -37.0% -32.1% -17.7% -68.0% -68.00%
FCF Margin -1.0% -1.1% -84.0% -92.2% -87.7% -81.9% -81.3% -78.5% -71.3% -64.8% -56.4% -59.4% -57.5% -56.1% -57.0% -40.4% -40.45%
OCF Margin -95.0% -97.2% -74.1% -83.2% -78.5% -70.7% -71.5% -69.7% -63.2% -60.6% -52.6% -55.5% -54.9% -53.8% -54.0% -38.1% -38.13%
ROA 3Y Avg snapshot only -44.49%
ROIC 3Y Avg snapshot only -59.57%
ROIC Economic snapshot only -39.96%
Cash ROA snapshot only -27.07%
Cash ROIC snapshot only -60.63%
CROIC snapshot only -64.31%
NOPAT Margin snapshot only -38.09%
Pretax Margin snapshot only -59.28%
R&D / Revenue snapshot only 24.70%
SGA / Revenue snapshot only 83.83%
SBC / Revenue snapshot only 11.24%
Valuation
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Current
P/E Ratio -104.21 -30.20 -16.36 -8.03 -7.65 -6.41 -5.15 -4.29 -3.93 -3.19 -3.78 -3.39 -1.92 -2.32 -2.05 -1.45 -1.152
P/S Ratio 44.35 19.54 13.36 6.91 7.50 6.38 4.86 3.95 3.53 2.49 2.48 2.47 1.24 1.55 1.39 0.86 0.789
P/B Ratio 3.92 3.78 4.70 3.86 5.32 5.93 6.21 7.44 4.18 3.67 4.46 7.05 5.20 9.88 14.94 -11.72 8.394
P/FCF -43.39 -18.12 -15.91 -7.50 -8.55 -7.79 -5.98 -5.03 -4.95 -3.84 -4.39 -4.15 -2.16 -2.77 -2.44 -2.13 -2.134
P/OCF — — — — — — — — — — — — — — — — —
EV/EBITDA -129.65 -32.44 -16.98 -8.43 -8.36 -7.25 -6.09 -5.53 -4.63 -4.12 -5.31 -5.11 -3.71 -4.62 -4.38 -4.22 -4.217
EV/Revenue 36.50 16.26 11.48 6.07 7.01 6.15 4.79 4.14 3.33 2.45 2.51 2.72 1.66 2.12 1.99 1.57 1.566
EV/EBIT -99.15 -27.53 -15.03 -7.49 -7.53 -6.52 -5.43 -4.90 -4.09 -3.56 -4.44 -4.34 -3.07 -3.85 -3.63 -3.38 -3.376
EV/FCF -35.71 -15.07 -13.67 -6.58 -7.99 -7.51 -5.89 -5.27 -4.66 -3.78 -4.44 -4.57 -2.90 -3.77 -3.49 -3.87 -3.871
Earnings Yield -1.0% -3.3% -6.1% -12.4% -13.1% -15.6% -19.4% -23.3% -25.4% -31.4% -26.4% -29.5% -52.2% -43.1% -48.8% -68.9% -68.85%
FCF Yield -2.3% -5.5% -6.3% -13.3% -11.7% -12.8% -16.7% -19.9% -20.2% -26.0% -22.8% -24.1% -46.3% -36.2% -41.0% -46.9% -46.85%
EV/Gross Profit snapshot only 2.536
Shareholder Yield snapshot only 0.00%
Leverage & Solvency
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Current
Current Ratio 8.67 8.42 5.09 3.98 3.55 3.53 3.03 2.76 3.37 3.29 3.45 3.07 2.73 2.75 2.61 0.61 0.613
Quick Ratio 8.31 8.07 4.76 3.63 3.16 3.11 2.64 2.32 2.94 2.76 2.94 2.38 1.98 1.85 1.78 0.40 0.401
Debt/Equity 0.22 0.24 0.27 0.41 0.62 0.88 1.29 1.79 1.05 1.21 1.59 2.60 3.81 6.23 11.08 -14.22 -14.217
Net Debt/Equity -0.69 -0.64 -0.66 -0.47 -0.35 -0.21 -0.09 0.36 -0.25 -0.06 0.05 0.72 1.77 3.60 6.47 — —
Debt/Assets 0.16 0.17 0.17 0.23 0.30 0.37 0.43 0.49 0.40 0.42 0.48 0.55 0.59 0.65 0.67 0.74 0.743
Debt/EBITDA -8.93 -2.47 -1.14 -1.02 -1.04 -1.11 -1.29 -1.27 -1.24 -1.38 -1.88 -1.71 -2.02 -2.13 -2.27 -2.82 -2.820
Net Debt/EBITDA 27.88 6.56 2.78 1.17 0.59 0.27 0.09 -0.25 0.29 0.06 -0.06 -0.47 -0.94 -1.23 -1.32 -1.89 -1.892
Interest Coverage -6.36 -10.31 -13.80 -15.50 -18.71 -18.55 -14.48 -11.44 -9.62 -7.58 -6.22 -6.29 -5.18 -4.71 -4.29 -3.60 -3.598
Equity Multiplier 1.40 1.42 1.57 1.76 2.03 2.35 3.00 3.66 2.63 2.86 3.35 4.73 6.46 9.53 16.46 -19.13 -19.129
Cash Ratio snapshot only 0.255
Debt Service Coverage snapshot only -2.880
Cash to Debt snapshot only 0.329
FCF to Debt snapshot only -0.386
Defensive Interval snapshot only 163.2 days
Efficiency & Turnover
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Current
Asset Turnover 0.06 0.14 0.22 0.32 0.33 0.38 0.41 0.46 0.46 0.52 0.54 0.61 0.56 0.57 0.53 0.60 0.598
Inventory Turnover 0.75 1.63 1.76 2.00 2.56 2.95 2.68 2.61 2.56 2.49 2.61 2.30 2.02 1.76 1.60 1.33 1.335
Receivables Turnover 1.60 2.76 4.52 5.27 6.92 7.63 7.81 6.54 7.28 7.38 7.23 7.08 6.34 6.01 5.31 6.34 6.342
Payables Turnover 1.01 2.45 1.68 1.97 2.77 4.61 3.14 3.35 3.00 3.95 3.77 4.43 3.85 3.74 3.29 2.91 2.908
DSO 228 132 81 69 53 48 47 56 50 49 50 52 58 61 69 58 57.5 days
DIO 485 223 207 183 143 124 136 140 142 146 140 159 180 208 228 273 273.5 days
DPO 362 149 217 185 132 79 116 109 122 92 97 82 95 98 111 126 125.5 days
Cash Conversion Cycle 351 206 71 67 64 93 67 86 71 104 94 128 143 171 186 206 205.5 days
Fixed Asset Turnover snapshot only 6.616
Operating Cycle snapshot only 331.0 days
Cash Velocity snapshot only 2.903
Capital Intensity snapshot only 1.409
Growth (YoY)
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Current
Revenue — — — — 3.9% 1.6% 75.3% 33.2% 31.9% 30.9% 29.1% 17.9% 9.7% -5.0% -15.5% -14.5% -14.55%
Net Income — — — — -10.4% -3.0% -1.0% -42.5% -20.8% -2.8% 10.4% 6.9% 21.0% 18.8% 12.6% 30.1% 30.10%
EPS — — — — -8.1% -3.0% -98.7% -39.3% -11.8% 20.4% 30.6% 27.5% 35.0% 19.7% 13.4% 30.8% 30.77%
FCF — — — — -3.2% -99.8% -69.7% -13.5% -7.3% -3.6% 10.4% 10.8% 11.6% 17.8% 14.6% 41.8% 41.82%
EBITDA — — — — -13.7% -3.5% -1.0% -38.5% -13.0% 8.2% 22.4% 16.2% 31.5% 26.8% 18.6% 40.4% 40.37%
Op. Income — — — — -8.5% -2.8% -95.3% -38.2% -15.8% 1.2% 14.2% 10.1% 24.1% 23.4% 17.8% 37.0% 37.00%
OCF Growth snapshot only 41.28%
Asset Growth snapshot only -27.21%
Equity Growth snapshot only -1.18%
Debt Growth snapshot only -1.72%
Shares Change snapshot only 0.97%
Growth (CAGR)
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Current
Revenue 3Y — — — — — — — — — — — — 92.5% 48.4% 24.1% 10.3% 10.29%
Revenue 5Y — — — — — — — — — — — — — — — — —
EPS 3Y — — — — — — — — — — — — — — — — —
EPS 5Y — — — — — — — — — — — — — — — — —
Net Income 3Y — — — — — — — — — — — — — — — — —
Net Income 5Y — — — — — — — — — — — — — — — — —
EBITDA 3Y — — — — — — — — — — — — — — — — —
EBITDA 5Y — — — — — — — — — — — — — — — — —
Gross Profit 3Y — — — — — — — — — — — — 85.3% 42.7% 21.3% 10.2% 10.18%
Gross Profit 5Y — — — — — — — — — — — — — — — — —
Op. Income 3Y — — — — — — — — — — — — — — — — —
Op. Income 5Y — — — — — — — — — — — — — — — — —
FCF 3Y — — — — — — — — — — — — — — — — —
FCF 5Y — — — — — — — — — — — — — — — — —
OCF 3Y — — — — — — — — — — — — — — — — —
OCF 5Y — — — — — — — — — — — — — — — — —
Assets 3Y — — — — — — — — — — — — -11.4% -12.7% -13.2% -15.6% -15.56%
Assets 5Y — — — — — — — — — — — — — — — — —
Equity 3Y — — — — — — — — — — — — -46.8% -53.7% -60.3% — —
Book Value 3Y — — — — — — — — — — — — -55.0% -57.9% -63.9% — —
Dividend 3Y — — — — — — — — — — — — — — — — —
Growth Quality
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Current
Revenue Stability — — — — — — — — 0.94 0.96 0.99 0.99 0.88 0.78 0.62 0.48 0.483
Earnings Stability — — — — — — — — 0.88 0.78 0.57 0.54 0.54 0.40 0.21 0.03 0.028
Margin Stability — — — — — — — — 0.94 0.95 0.94 0.93 0.94 0.95 0.95 0.94 0.935
Rev. Growth Consistency 0.00 0.00 0.00 0.00 0.50 0.50 0.50 0.50 1.00 1.00 1.00 1.00 1.00 0.00 0.00 0.00 0.000
Earn. Growth Consistency 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.50 0.50 0.50 0.50 1.00 1.00 1.000
FCF Positive Streak 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Earnings Persistence — — — — — — — — 0.92 0.99 0.96 0.97 0.92 0.92 0.95 0.88 0.880
Earnings Smoothness — — — — — — — — — — — — — — — — —
ROE Trend — — — — — — — — -0.70 -0.63 -0.43 -0.97 -1.83 -3.21 -6.10 — —
Gross Margin Trend — — — — — — — — -0.06 -0.04 -0.04 -0.06 -0.03 -0.03 0.01 0.06 0.060
FCF Margin Trend — — — — — — — — 0.24 0.30 0.26 0.26 0.22 0.17 0.12 0.29 0.285
Sustainable Growth Rate — — — — — — — — — — — — — — — — —
Internal Growth Rate — — — — — — — — — — — — — — — — —
Cash Flow Quality
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Current
OCF/Net Income 2.23 1.50 0.91 0.97 0.80 0.71 0.76 0.76 0.70 0.77 0.80 0.76 0.85 0.81 0.80 0.64 0.642
FCF/OCF 1.08 1.11 1.13 1.11 1.12 1.16 1.14 1.13 1.13 1.07 1.07 1.07 1.05 1.04 1.06 1.06 1.061
FCF/Net Income snapshot only 0.680
CapEx/Revenue 7.2% 10.6% 9.8% 8.9% 9.2% 11.3% 9.8% 8.9% 8.1% 4.3% 3.8% 3.9% 2.6% 2.3% 3.0% 2.3% 2.31%
CapEx/Depreciation snapshot only 0.250
Accruals Ratio 0.03 0.04 -0.02 -0.01 -0.06 -0.11 -0.09 -0.10 -0.12 -0.09 -0.07 -0.10 -0.06 -0.07 -0.07 -0.13 -0.127
Sloan Accruals snapshot only -0.882
Cash Flow Adequacy snapshot only -16.483
Dividends & Buybacks
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Current
Dividend Yield 0.0% 0.0% 0.3% 0.3% 0.3% 0.3% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.00%
Dividend/Share $0.00 $0.00 $0.04 $0.04 $0.04 $0.04 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Payout Ratio — — — — — — — — — — — — — — — — —
FCF Payout Ratio — — — — — — — — — — — — — — — — —
Total Payout Ratio — — — — — — — — — — — — — — — — —
Div. Increase Streak — — 0 0 0 0 — — — — — — — — — — —
Chowder Number — — — — — — — — — — — — — — — — —
Buyback Yield 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.00%
Net Buyback Yield -23.9% -26.7% -24.4% -33.7% -0.1% -0.1% -0.1% -0.1% -16.1% -21.2% -20.1% -20.9% -0.0% -0.1% -0.1% -0.1% -0.09%
Total Shareholder Return -23.9% -26.7% -24.1% -33.4% 0.2% 0.2% -0.1% -0.1% -16.1% -21.2% -20.1% -20.9% -0.0% -0.1% -0.1% -0.1% -0.09%
DuPont Factors
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Current
Tax Burden (NI/EBT) 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.003
Interest Burden (EBT/EBIT) 1.16 1.10 1.07 1.06 1.05 1.05 1.07 1.09 1.10 1.13 1.16 1.16 1.19 1.21 1.23 1.28 1.278
EBIT Margin -0.37 -0.59 -0.76 -0.81 -0.93 -0.94 -0.88 -0.84 -0.81 -0.69 -0.56 -0.63 -0.54 -0.55 -0.55 -0.46 -0.464
Asset Turnover 0.06 0.14 0.22 0.32 0.33 0.38 0.41 0.46 0.46 0.52 0.54 0.61 0.56 0.57 0.53 0.60 0.598
Equity Multiplier 1.40 1.42 1.57 1.76 1.64 1.75 2.04 2.30 2.29 2.58 3.17 4.13 3.53 4.06 4.98 9.96 9.965
Per Share
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Current
EPS (Diluted TTM) $-0.19 $-0.46 $-0.94 $-1.37 $-1.68 $-1.83 $-1.86 $-1.91 $-1.88 $-1.46 $-1.29 $-1.38 $-1.22 $-1.17 $-1.12 $-0.96 $-0.96
Book Value/Share $4.93 $3.70 $3.26 $2.84 $2.42 $1.98 $1.54 $1.10 $1.77 $1.27 $1.10 $0.67 $0.45 $0.28 $0.15 $-0.12 $0.15
Tangible Book/Share $3.60 $2.63 $2.20 $1.80 $1.38 $0.96 $0.53 $0.11 $0.85 $0.52 $0.37 $-0.05 $-0.24 $-0.40 $-0.51 $-0.77 $-0.77
Revenue/Share $0.44 $0.71 $1.15 $1.59 $1.71 $1.84 $1.97 $2.07 $2.09 $1.87 $1.97 $1.90 $1.89 $1.75 $1.65 $1.61 $1.65
FCF/Share $-0.45 $-0.77 $-0.96 $-1.47 $-1.50 $-1.51 $-1.60 $-1.63 $-1.49 $-1.21 $-1.11 $-1.13 $-1.08 $-0.98 $-0.94 $-0.65 $-0.94
OCF/Share $-0.41 $-0.69 $-0.85 $-1.32 $-1.34 $-1.30 $-1.41 $-1.44 $-1.32 $-1.13 $-1.04 $-1.06 $-1.04 $-0.94 $-0.89 $-0.61 $-0.89
Cash/Share $4.52 $3.23 $3.04 $2.51 $2.33 $2.16 $2.14 $1.57 $2.30 $1.60 $1.69 $1.25 $0.92 $0.73 $0.71 $0.55 $0.71
EBITDA/Share $-0.12 $-0.36 $-0.78 $-1.14 $-1.44 $-1.56 $-1.55 $-1.55 $-1.50 $-1.11 $-0.93 $-1.01 $-0.85 $-0.80 $-0.75 $-0.60 $-0.60
Debt/Share $1.10 $0.89 $0.88 $1.17 $1.49 $1.73 $1.99 $1.96 $1.86 $1.53 $1.75 $1.73 $1.71 $1.72 $1.70 $1.69 $1.69
Net Debt/Share $-3.42 $-2.35 $-2.15 $-1.34 $-0.84 $-0.42 $-0.14 $0.39 $-0.43 $-0.07 $0.05 $0.48 $0.80 $0.99 $0.99 $1.13 $1.13
Academic Models
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Current
Altman Z-Score — — — — — — — — — — — — — — — — -4.215
Altman Z-Prime snapshot only -12.753
Piotroski F-Score 1 1 2 2 2 2 2 2 2 3 4 4 4 4 2 3 3
Beneish M-Score — — — — -2.58 -2.96 -2.77 -2.84 -2.75 -2.25 -2.19 -2.81 -2.52 -3.04 -3.17 -3.44 -3.436
Ohlson O-Score snapshot only -1.922
Net-Net WC snapshot only $-1.05
EVA snapshot only $-35489030.00
Credit
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Current
Credit Rating snapshot only CCC
Credit Score 54.91 55.24 55.42 42.72 42.65 33.11 31.99 24.60 26.41 26.44 25.68 24.69 21.77 20.62 20.36 12.75 12.748
Credit Grade snapshot only 17
Credit Trend snapshot only -11.941
Implied Spread (bps) snapshot only 1200.000
Industry Credit Rank snapshot only 0
Sector Credit Rank snapshot only 1

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms